Assenagon Asset Management S.A. Landec Corp \Ca\ Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	N/A	-51,539 Reduced 68.36%	23,852 $0
Q4 2022 Jan 12, 2023	SELL	$0.0 - $9.95 $0 - $730,449	-73,412 Reduced 49.34%	75,391 $489,000
Q3 2022 Oct 27, 2022	SELL	$8.57 - $11.57 $917,041 - $1.24 Million	-107,006 Reduced 41.83%	148,803 $1.32 Million
Q2 2022 Jul 27, 2022	SELL	$8.84 - $11.64 $872,649 - $1.15 Million	-98,716 Reduced 27.84%	255,809 $2.55 Million
Q1 2022 Apr 25, 2022	SELL	$10.07 - $11.93 $1.01 Million - $1.2 Million	-100,465 Reduced 22.08%	354,525 $4.11 Million
Q4 2021 Feb 01, 2022	BUY	$7.95 - $11.24 $3.49 Million - $4.94 Million	439,339 Added 2807.1%	454,990 $5.05 Million
Q3 2021 Oct 19, 2021	BUY	$9.22 - $12.44 $144,302 - $194,698	15,651 New	15,651 $144,000

20.3M

79.7K

31.6K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.